Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prayudi Santoso

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Tuberculosis and Respiratory Diseases|January 20, 2022
Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of MitochondriaAmaylia Oehadian, Prayudi Santoso, Dick Menzies, et al.
Idcases|August 12, 2022
Anemia with elevation of growth differentiation factor-15 level in linezolid treated multidrug-resistant tuberculosis: Case series of three patientsAmaylia Oehadian, Prayudi Santoso, Dick Menzies, et al.
International Journal of General Medicine|December 4, 2023
The Kynurenine/Tryptophan Ratio as a Promising Metabolomic Biomarker for Diagnosing the Spectrum of Tuberculosis Infection and DiseaseFitri Fadhilah, Agnes Rengga Indrati, Sumartini Dewi, et al.
Frontiers in Pharmacology|January 2, 2023
Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parametersNurul Annisa, Melisa I Barliana, Prayudi Santoso, et al.
Plos One|February 8, 2021
Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort studyArto Yuwono Soeroto, Chica Pratiwi, Prayudi Santoso, et al.
Patient Preference and Adherence|December 1, 2021
Between Curing and Torturing: Burden of Adverse Reaction in Drug-Resistant Tuberculosis TherapyYudisia Ausi, Prayudi Santoso, Deni Kurniadi Sunjaya, et al.
Journal of Multidisciplinary Healthcare|June 23, 2025
A Call to Action: Empowering Pharmacists in Drug-Resistant Tuberculosis ManagementMohammed Alfaqeeh, Prayudi Santoso, Jan-Willem Alffenaar, et al.
Pathogens (Basel, Switzerland)|May 27, 2026
RISK6 as a Translational Host Transcriptomic Signature for Tuberculosis Diagnosis, Treatment Monitoring, and Risk StratificationChrispian Mamudi, Purnamawati, Panca Andana, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|March 4, 2022
Risk factors of latent tuberculosis among chronic kidney disease with routine haemodialysis patientsRia Bandiara, Astried Indrasari, Anggi Dewi Rengganis, et al.
The Clinical Respiratory Journal|September 25, 2024
Chest X-Ray Comparison Between Drug-Resistant and Drug-Sensitive Pulmonary Tuberculosis in ChildrenSaffanah Az Zuhriyyah, Harry Galuh Nugraha, Djatnika Setiabudi, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Tuberculosis and Respiratory Diseases|January 20, 2022
Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of MitochondriaAmaylia Oehadian, Prayudi Santoso, Dick Menzies, et al.
Idcases|August 12, 2022
Anemia with elevation of growth differentiation factor-15 level in linezolid treated multidrug-resistant tuberculosis: Case series of three patientsAmaylia Oehadian, Prayudi Santoso, Dick Menzies, et al.
International Journal of General Medicine|December 4, 2023
The Kynurenine/Tryptophan Ratio as a Promising Metabolomic Biomarker for Diagnosing the Spectrum of Tuberculosis Infection and DiseaseFitri Fadhilah, Agnes Rengga Indrati, Sumartini Dewi, et al.
Frontiers in Pharmacology|January 2, 2023
Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parametersNurul Annisa, Melisa I Barliana, Prayudi Santoso, et al.
Plos One|February 8, 2021
Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort studyArto Yuwono Soeroto, Chica Pratiwi, Prayudi Santoso, et al.
Patient Preference and Adherence|December 1, 2021
Between Curing and Torturing: Burden of Adverse Reaction in Drug-Resistant Tuberculosis TherapyYudisia Ausi, Prayudi Santoso, Deni Kurniadi Sunjaya, et al.
Journal of Multidisciplinary Healthcare|June 23, 2025
A Call to Action: Empowering Pharmacists in Drug-Resistant Tuberculosis ManagementMohammed Alfaqeeh, Prayudi Santoso, Jan-Willem Alffenaar, et al.
Pathogens (Basel, Switzerland)|May 27, 2026
RISK6 as a Translational Host Transcriptomic Signature for Tuberculosis Diagnosis, Treatment Monitoring, and Risk StratificationChrispian Mamudi, Purnamawati, Panca Andana, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|March 4, 2022
Risk factors of latent tuberculosis among chronic kidney disease with routine haemodialysis patientsRia Bandiara, Astried Indrasari, Anggi Dewi Rengganis, et al.
The Clinical Respiratory Journal|September 25, 2024
Chest X-Ray Comparison Between Drug-Resistant and Drug-Sensitive Pulmonary Tuberculosis in ChildrenSaffanah Az Zuhriyyah, Harry Galuh Nugraha, Djatnika Setiabudi, et al.
Pageof 4